17 results
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Antidepressants #SSRIs #Evidence ... Publication #Bias #Comparison ... #FDA #NEJM
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Goal-Directed Therapy - Evidence ... Trials - EGDT: NEJM ... - ProCESS: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
PCI in Acute MI ... #EBM #Cardiology ... #CULPRITSHOCK #PCI ... VisualAbstract #NEJM
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Pathophys #Management #EM ... #IM #PCC #Catecholamine ... #Comparison #Table
Assessment and Treatment of Severe Asthma, According to Inflammatory Phenotypes, in Patients without a Response to
milliliter and evidence ... #Management #PCC ... Algorithm #Phenotypes #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Clinical Trials and Evidence ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... UGIB TRISS - NEJM ... /vmoitra) #EBM
Rate of Survival and the Risk of Death at 90 Days, According to Subgroup #EBM #PCC
According to Subgroup #EBM ... #PCC #ADRENAL # ... #SepticShock #NEJM
Associations between Total Mucin Concentrations and Phlegm Production and Disease Severity in Chronic Obstructive Pulmonary Disease
#EBM #Pathophys ... #PCC #Bronchitis ... ChronicBronchitis #Mucin #NEJM
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Antidepressants #SSRIs #Evidence ... Publication #Bias #Comparison ... #FDA #NEJM
Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According
Nitric Oxide #EBM ... #PCC #Asthma #Tezepelumab ... #NEJM